An experimental drug was found to show potential as an Alzheimer's treatment in new trial results, but the findings also raised some safety concerns
The experimental drug lecanemab shows “potential” as an Alzheimer’s disease treatment, according to new Phase 3 trial results, but the findings raise some safety concerns because of its association with certain serious adverse events. Lecanemab has become one of the first experimental dementia drugs to appear to slow the progression of cognitive decline.
brain bleeding was seen among 17.3% of those who received lecanemab and 9% of those in the placebo group; may not have symptoms, but it can occasionally lead to hospitalization or lasting impairment. And the frequency of
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
I tried an experimental treatment for binge eating and it workedWeight-loss surgery failed for Robyn Baldwin so she tried deep brain stimulation to get her food cravings under control.
続きを読む »
Experimental flu shot aims to target 20 influenza viruses in a single vaccineCan this experimental flu vaccine target 20 viruses with just one shot? Researchers say yes, but here's why it's been so difficult to develop a universal flu vaccine.
続きを読む »
Experimental flu shot aims to target 20 influenza viruses in a single vaccineFor a half-century, scientists have been trying to develop a vaccine that would protect against the most dangerous flu viruses. Now, researchers have a new approach based on the mRNA technology that proved so effective against COVID-19.
続きを読む »
At Least Two Deaths Have Now Been Linked to an Experimental Alzheimer's TreatmentAn investigative report suggests that lecanemab can raise the risk of severe brain bleeding when taken with a blood thinner.
続きを読む »